GET THE APP

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

	2022	2021	2020	2019	2018
Year wise published articles	32	59	77	13	11
Year wise citations received	172	256	226	169	197

Journal total citations count	1776
Journal impact factor	5.32
Journal 5 years impact factor	5.62
Journal cite score	5.3
Journal h-index	22
Journal h-index since 2018	17

Important citations (1101)

dilintas a (2016) the emerging threat of the middle east respiratory syndrome-coronavirus (mers-cov). archives of hellenic medicine/arheia ellenikes iatrikes 1: 33. View at Publisher View at Google Scholar
ahmadinejad f, honardoost ma, amiri m, jami ms (2015) genetics and epidemiology of middle east respiratory syndrome-coronavirus (mers-cov). international journal of epidemiologic research 2: 204-208. View at Publisher View at Google Scholar
mcdonagh p (2011) novel antiviral strategies for feline coronavirus and feline calicivirus. View at Publisher View at Google Scholar
elbur a, alharthi a, aljuaid a, hasan n (2011) knowledge of middle east respiratory syndrome coronavirus (mers-cov) and its management: a survey among saudi people in taif; kingdom of saudi arabia. View at Publisher View at Google Scholar
malik m, elkholy aa, khan w, hassounah s, abubakar a, et al. (2016) middle east respiratory syndrome coronavirus: current knowledge and future considerations. eastern mediterranean health journal 22: 537. View at Publisher View at Google Scholar
east po. world journal of pharmaceutical research. View at Publisher View at Google Scholar
parlak e (2015) middle east respiratory syndrome: mers. journal of microbiology and infectious diseases 5: 2. View at Publisher View at Google Scholar
long y, xu y, wang b, zhang l, jia d, et al. (2016) clinical recommendations from an observational study on mers: glucocorticoids was benefit in treating sars patients. int j clin exp med 9: 8865-8873. View at Publisher View at Google Scholar
yamamoto m, matsuyama s, li x, takeda m, kawaguchi y, et al. (2016) identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. antimicrobial agents and chemotherapy. 60: 6532-6539. View at Publisher View at Google Scholar
li xing-zhou, zhou xin-bo, zhong wu (2015) progress in clinical treatment and small molecule therapy in the middle east respiratory syndrome. international journal of pharmaceutical research 42: 296-302. View at Publisher View at Google Scholar
li ye, lu ye, li lianhong, hu guoqing (2014) preparation and protection measures of health care workers in response to respiratory syndrome in the middle east. chinese journal of disinfection 1: 60-62. View at Publisher View at Google Scholar
rhee jy, hong g, ryu km (2016) clinical implications of 5 cases of middle east respiratory syndrome coronavirus infection in a south korean outbreak. japanese journal of infectious diseases 69: 361-366. View at Publisher View at Google Scholar
omrani as, memish za (2015) therapeutic options for middle east respiratory syndrome coronavirus (mers-cov) infection: how close are we?. current treatment options in infectious diseases 7: 202-216. View at Publisher View at Google Scholar
al-tawfiq ja, omrani as, memish za (2016) middle east respiratory syndrome coronavirus: current situation and travel-associated concerns. frontiers of medicine 10: 111-119. View at Publisher View at Google Scholar
coleman cm, frieman mb (2014) treating mers-cov during an outbreak. the lancet infectious diseases 14: 1030. View at Publisher View at Google Scholar
balkhair a, alawi fb, al maamari k, al muharrmi z, ahmed o (2014) mers-cov: bridging the knowledge gaps. oman med j 29: 169-171. View at Publisher View at Google Scholar
chong yp, song jy, seo yb, choi jp, shin hs, et al. (2015) antiviral treatment guidelines for middle east respiratory syndrome. infection & chemotherapy 47: 212-222. View at Publisher View at Google Scholar
peters hl, jochmans d, de wilde ah, posthuma cc, snijder ej, et al. (2015) design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. bioorganic & medicinal chemistry letters. 25: 2923-2926. View at Publisher View at Google Scholar
kim uj, won ej, kee sj, jung si, jang hc (2016) case report combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for middle east respiratory syndrome. antiviral therapy 21: 455-459. View at Publisher View at Google Scholar
al-tawfiq ja, memish za (2015) managing mers-cov in the healthcare setting. hospital practice 43: 158-163. View at Publisher View at Google Scholar
Prev 1 2 ... 37 38 39 40 41 42 43 44 45 46 47 ... 55 56 Next »

Top